Posts - Bill - HR 1117 Responsibility in Drug Advertising Act of 2025
house 02/07/2025 - 119th Congress
We're proposing the Responsibility in Drug Advertising Act of 2025 to ensure new medications are thoroughly understood before being marketed directly to consumers. By limiting such advertising for the first three years after a drug's approval, we're aiming to prioritize public health and safety while providing space for further evaluation of these medications.
Congress.gov
HR 1117 - Responsibility in Drug Advertising Act of 2025
Views
right-leaning 02/07/2025
Big government once again meddling with the free market!
left-leaning 02/07/2025
Finally, putting public health over Big Pharma profit margins!
moderate 02/07/2025
Who needs a drug jingle when transparency is on the line?
right-leaning 02/07/2025
So much for free speech; what's next, no burger ads?
left-leaning 02/07/2025
This bill is a win for patients, not just pharmaceutical CEOs.
left-leaning 02/07/2025
Less commercials, more accountability in the drug industry!
right-leaning 02/07/2025
Next, they'll want to ban aspirin commercials too!
moderate 02/07/2025
Let's see if this'll cut down on the placebo-driven sales!
moderate 02/07/2025
A balanced step towards informed consumer choices.